1/127
Looks like no tags are added yet.
Warfarin plasma concentration limitation
have a poor relationship with biological effects, so plasma concentrations are not routinely used to guide therapy.
what should you monitor daily when on any anticoagulant
signs and symptoms of bleeding and thrombosis.
how much should you adjust doses of warfarin by
small increments of approximately 5–20% of the total weekly dose.
bile acid sequestriants (Cholestyramine/Colestipol ) + warfarin
Binds warfarin in the GI tract and decreases its absorption.
UFH drug class
Indirect anticoagulant
UFH use
Treatment of active thrombosis, setting of ACS, prevention of clot formation, prolongation of catheters
what weight is used of UPH dosing
total body weight.
When is a UFH bolus dose not needed
high bleeding risk, rapid anticoagulation is not needed
UFH therapeutic aPTT range
46–70 seconds.
UFH aPTT or anti-Xa monitoring frequency after initiation
Check 4–8 hours after initiation.
UFH aPTT or anti-Xa monitoring freq after a rate change
Check 4–8 hours after the change.
UFH aPTT or anti-Xa monitoring freq once therapeutic
Every 24 hours.
UFH monitoring freq during extracorporeal circulation
aPTT every 30–60 minutes.
Why are platelets monitored in patients receiving UFH
possibility of developing heparin-induced thrombocytopenia with thrombosis (HITT).
Why is Hgb/Hct monitored in patients receiving UFH
decreases may be early indicators of bleeding.
Heparin patients should monitor what daily
signs and symptoms of bleeding or thrombosis.
LMWH is derived from what
from unfractionated heparin.
LMWH size compared with UFH
Approximately one-third the molecular weight
LMWH pentasaccharide-containing sequence is required for what
antithrombin binding (found on less than one-third of LMWH molecules)